Recent developments in the treatment of small cell lung cancer

Small cell lung cancer (SCLC) comprises about 15% of all lung cancers. It is an aggressive disease, with early metastasis and a poor prognosis. Until recently, SCLC treatment remained relatively unchanged, with chemotherapy remaining the cornerstone of treatment. In this overview we will highlight t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiddinga, Birgitta I., Raskin, Jo, Janssens, Annelies, Pauwels, Patrick, Van Meerbeeck, Jan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488550/
https://www.ncbi.nlm.nih.gov/pubmed/34261744
http://dx.doi.org/10.1183/16000617.0079-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488550/
https://www.ncbi.nlm.nih.gov/pubmed/34261744
http://dx.doi.org/10.1183/16000617.0079-2021

Ejemplares similares